Last reviewed · How we verify
NCT04483362
CanMove: A Physical Activity Program for Children With Cancer
NA trial testing Complex physical activity intervention in Pediatric Cancer in 21 participants. Completed in 3 September 2021.
3 September 2021
Quick facts
| Lead sponsor | Murdoch Childrens Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 21 |
| Start date | 9 November 2020 |
| Primary completion | 3 September 2021 |
| Estimated completion | 3 September 2021 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Complex physical activity intervention
Conditions studied
- Pediatric Cancer — all drugs for Pediatric Cancer →
Sponsor
Murdoch Childrens Research Institute
Who can join
Adults 5 to 17, any sex, with Pediatric Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate a physical activity intervention for children during acute cancer treatment. The intervention aims to encourage children to participate in increased levels of physical activity and reduce the amount of time they spend engaged in sedentary activities. This study also aims to evaluate different ways of assessing physical function in order to determine the best outcome measure to use for children during acute cancer treatment.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Promoting positive physical activity behaviours in children undergoing acute cancer treatment: feasibility of the CanMOVE intervention.
Grimshaw SL, Taylor NF, Conyers R, Shields N. · · 2024 · cited 3× · PMID 38271785 · DOI 10.1016/j.bjpt.2023.100577 -
Evaluating the measurement properties and feasibility of physical activity and physical function assessments for children undergoing acute cancer treatment.
Grimshaw SL, Taylor NF, Conyers R, Shields N. · · 2024 · PMID 41878660 · DOI 10.1016/j.jsampl.2024.100065
Verify or expand the search:
- PubMed search for NCT04483362
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric Cancer
Currently open trials in the same condition.
- NCT07506239 — Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma · NA · recruiting
- NCT07278778 — Cancer Care Companion · NA · recruiting
- NCT07473518 — Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy · recruiting
- NCT06939322 — LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) · NA · recruiting
- NCT07188311 — Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma · NA · recruiting
Other Murdoch Childrens Research Institute trials
Trials by the same sponsor.
- NCT07251790 — Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study · NA · not yet recruiting
- NCT07136584 — SOS for Caregiver Wellbeing · NA · recruiting
- NCT06686446 — Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial · NA · terminated
- NCT06992141 — A Strep Throat Controlled Human Infection Trial in Healthy Adults · EARLY_PHASE1 · completed
- NCT06186141 — Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04483362 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Murdoch Childrens Research Institute
- Last refreshed: 3 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04483362.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing